China Universal Asset Management Co., Ltd. Alnylam Pharmaceuticals, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $773 Million
- Q1 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 35,822 shares of ALNY stock, worth $8.91 Million. This represents 0.69% of its overall portfolio holdings.
Number of Shares
35,822
Previous 35,822
-0.0%
Holding current value
$8.91 Million
Previous $5.35 Million
0.02%
% of portfolio
0.69%
Previous 0.68%
Shares
12 transactions
Others Institutions Holding ALNY
# of Institutions
585Shares Held
104MCall Options Held
2.82MPut Options Held
1.75M-
Capital World Investors Los Angeles, CA12.8MShares$3.18 Billion0.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$2.98 Billion0.04% of portfolio
-
Black Rock Inc. New York, NY9.03MShares$2.24 Billion0.03% of portfolio
-
Wellington Management Group LLP Boston, MA7.21MShares$1.79 Billion0.2% of portfolio
-
Baillie Gifford & CO6.62MShares$1.65 Billion0.78% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $30.6B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...